Basics Harvard Bioscience, Inc. Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing. IPO Date: April 1, 2001 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $16.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 2.51% Avg Daily Range (30 D): $0.03 | 8.86% Avg Daily Range (90 D): $0.04 | 6.26% Institutional Daily Volume Avg Daily Volume: .19M Avg Daily Volume (30 D): 15.47M Avg Daily Volume (90 D): 5.45M Trade Size Avg Trade Size (Sh.): 278 Avg Trade Size (Sh.) (30 D): 948 Avg Trade Size (Sh.) (90 D): 862 Institutional Trades Total Inst.Trades: 158 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.69M Avg Inst. Trade Volume: .41M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.09M Avg Closing Trade (30 D): $.96M Avg Closing Trade (90 D): $.96M Avg Closing Volume: 1.46M         News May 12, 2025 @ 11:00 AM Harvard Bioscience Announces First Quarter 2025 Fi... Source: N/A Apr 10, 2025 @ 8:45 PM Harvard Bioscience Announces CFO Transition Source: N/A Mar 12, 2025 @ 8:00 PM Harvard Bioscience, Inc. to Participate in Two ... Source: N/A Feb 24, 2025 @ 4:00 PM Harvard Bioscience Schedules Fourth Quarter 2024 E... Source: N/A Jan 24, 2025 @ 9:58 AM Microelectrode Array In Vitro Market to Reach US$ ... Source: The Insight Partners Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.31 $-1.14 $.01 Diluted EPS $-1.31 $-1.14 $.01 Revenue $ 91.4M $ 21.77M $ 24.56M Gross Profit $ 52.18M $ 12.18M $ 14.01M Net Income / Loss $ -58.05M $ -50.34M $ .02M Operating Income / Loss $ -53.6M $ -49.67M $ .01M Cost of Revenue $ 39.22M $ 9.59M $ 10.55M Net Cash Flow $ .94M $ 1.1M $ -.1M PE Ratio